Relationship Between Insulin Resistance/Hyperinsulinemia and the Development of Atherosclerosis/Arteriosclerosis as the Cause of Cardiovascular Diseases
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Endocrinology and Metabolism Research".
Deadline for manuscript submissions: closed (30 April 2025) | Viewed by 671
Special Issue Editor
Interests: cardiovascular diseases; epidemiology; eHealth; public health
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cardiovascular diseases are the main cause of death in Western countries. Their common basis are adverse structural and functional changes within vascular walls, specifically atherosclerosis and arteriosclerosis, which tend to coexist, causing progressive, diffuse, and age-related deterioration in all vascular beds. Atherosclerosis is a chronic inflammatory and degenerative process that mainly occurs in large- and medium-sized arteries, and is morphologically characterized by asymmetric focal thickenings of the innermost layer of the artery, known as the intima. Arteriosclerosis refers to the degenerative stiffness in the arterial beds, defined as the reduced capability of an artery to expand and contract in response to pressure changes. The scope of this Special Issue is to unravel the associations between insulin resistance/hyperinsulinemia and atherosclerosis in the development of cardiovascular diseases from a molecular point of view to a population perspective.
Dr. Maria Grau
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- atherosclerosis
- arteriosclerosis
- insulin resistance
- hyperinsulinemia
- cardiovascular diseases
- carotid artery diseases
- coronary artery disease
- peripheral vascular diseases
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
